Riverstone (AP4) H2 2025 earnings summary

Executive summary

• Manufactures high-tech cleanroom gloves, premium healthcare gloves, and cleanroom consumables for electronics, semiconductor, and healthcare sectors.

• Operates regionally with production and sales sites in Malaysia, China, Thailand, and the Philippines.

• Diversified revenue streams from cleanroom and healthcare glove businesses.

Financial highlights

• FY2025 revenue was RM 995.3 million, down 7.2% year-over-year; Q4 revenue rose 1.3% sequentially.

• Gross profit for FY2025 was RM 298.7 million, a 23.4% decrease year-over-year; Q4 gross profit fell 3.0% sequentially.

• Net profit for FY2025 was RM 207.8 million, down 27.6% year-over-year; Q4 net profit increased 3.7% sequentially.

• Operating cash flow remained positive, with RM 306.3 million in Q4 FY2025.

• Maintained consistent dividend payout, with a payout ratio above 40% in recent years.

Outlook and guidance

• Focus on R&D, product innovation, and ESG initiatives to maintain competitive edge.

• Plans to optimize processes and reduce costs amid industry overcapacity and rising input costs.

• Ongoing investments in water and electricity savings, waste reduction, and renewable energy.